Table 1.
Age (weeks) | ||||||
---|---|---|---|---|---|---|
4 | 8 | 12 | ||||
Parameter | WT | FHL2 KO | WT | FHL2 KO | WT | FHL2 KO |
Body weight (g) | ||||||
Female | 12.82±0.71 | 11.80±0.55*, ** | 19.28±0.37** | 17.76±0.28*, **, *** | 22.12±0.50** | 20.90±0.56** |
Male | 15.28±0.43 | 13.17±0.82* | 23.96±0.39 | 23.23±0.62* | 27.80±0.91 | 27.25±0.93 |
Body length (mm) | ||||||
Female | 73.40±2.54 | 73.33±1.26 | 85.8±1.20** | 84.83±1.22** | 89.20±1.36** | 89.00±1.29** |
Male | 77.60±1.21 | 73.67±1.52 | 93.20±0.37 | 90.83±1.78 | 95.00±0.63 | 95.00±1.75 |
Femur BMC (mg) | ||||||
Female | 6.54±0.49 | 5.83±0.31* | 16.6±0.93 | 12.07±0.83*** | 19.48±0.22 | 17.27±0.74*** |
Male | 7.67±0.42 | 6.52±0.50* | 15.63±1.01 | 16.37±1.58 | 19.27±0.42 | 20.43±1.57 |
Femur BMD (mg/cm2) | ||||||
Female | 42.26±1.29 | 38.90±0.46 | 63.80±1.74** | 55.53±2.26**, *** | 72.02±1.03 | 67.12±1.49*** |
Male | 41.20±2.15 | 40.17±1.28 | 65.03±1.95 | 67.18±4.56 | 68.72±1.92 | 77.02±5.24 |
Tibia BMC (mg) | ||||||
Female | 7.60±0.49 | 7.50±0.43* | 16.74±1.01 | 14.07±0.56*** | 18.90±0.61 | 16.88±1.12 |
Male | 10.17±0.48 | 7.08±0.84* | 16.10±0.28 | 17.02±1.10 | 18.85±0.42 | 19.90±1.06 |
Tibia BMD (mg/cm2) | ||||||
Female | 34.58±1.13 | 33.00±1.16 | 53.00±2.09 | 47.82±0.95*** | 58.10±1.91 | 54.57±3.11 |
Male | 35.85±1.30 | 33.28±1.95 | 51.62±1.94 | 53.57±2.14 | 58.38±1.52 | 60.57±2.82 |
Significant main effect for treatment at P < 0.05
Significant main effect for gender at P < 0.05
Significant treatment effect for female mice at P < 0.05; n = 5 or 6 in each treatment group (n = 23)